| Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period SM Kissler, C Tedijanto, E Goldstein, YH Grad, M Lipsitch Science 368 (6493), 860-868, 2020 | 3139 | 2020 |
| BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting N Dagan, N Barda, E Kepten, O Miron, S Perchik, MA Katz, MA Hernán, ... New England Journal of Medicine 384 (15), 1412-1423, 2021 | 2883 | 2021 |
| Transmission dynamics and control of severe acute respiratory syndrome M Lipsitch, T Cohen, B Cooper, JM Robins, S Ma, L James, ... science 300 (5627), 1966-1970, 2003 | 1879 | 2003 |
| Defining the epidemiology of Covid-19—studies needed M Lipsitch, DL Swerdlow, L Finelli New England journal of medicine 382 (13), 1194-1196, 2020 | 1766 | 2020 |
| Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China JT Wu, K Leung, M Bushman, N Kishore, R Niehus, PM de Salazar, ... Nature medicine 26 (4), 506-510, 2020 | 1670 | 2020 |
| Covid-19 breakthrough infections in vaccinated health care workers M Bergwerk, T Gonen, Y Lustig, S Amit, M Lipsitch, C Cohen, ... New England Journal of Medicine 385 (16), 1474-1484, 2021 | 1538 | 2021 |
| How generation intervals shape the relationship between growth rates and reproductive numbers J Wallinga, M Lipsitch Proceedings of the Royal Society B: Biological Sciences 274 (1609), 599-604, 2007 | 1457 | 2007 |
| Negative controls: a tool for detecting confounding and bias in observational studies M Lipsitch, ET Tchetgen, T Cohen Epidemiology 21 (3), 383-388, 2010 | 1410 | 2010 |
| Serotype replacement in disease after pneumococcal vaccination DM Weinberger, R Malley, M Lipsitch The Lancet 378 (9807), 1962-1973, 2011 | 1108 | 2011 |
| Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting N Barda, N Dagan, Y Ben-Shlomo, E Kepten, J Waxman, R Ohana, ... New England Journal of Medicine 385 (12), 1078-1090, 2021 | 1104 | 2021 |
| Transmissibility of 1918 pandemic influenza CE Mills, JM Robins, M Lipsitch Nature 432 (7019), 904-906, 2004 | 1041 | 2004 |
| Public health interventions and epidemic intensity during the 1918 influenza pandemic RJ Hatchett, CE Mecher, M Lipsitch Proceedings of the National Academy of Sciences 104 (18), 7582-7587, 2007 | 981 | 2007 |
| Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study N Barda, N Dagan, C Cohen, MA Hernán, M Lipsitch, IS Kohane, BY Reis, ... The Lancet 398 (10316), 2093-2100, 2021 | 959 | 2021 |
| Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection R Malley, P Henneke, SC Morse, MJ Cieslewicz, M Lipsitch, ... Proceedings of the National Academy of Sciences 100 (4), 1966-1971, 2003 | 922 | 2003 |
| Model-informed COVID-19 vaccine prioritization strategies by age and serostatus KM Bubar, K Reinholt, SM Kissler, M Lipsitch, S Cobey, YH Grad, ... Science 371 (6352), 916-921, 2021 | 889 | 2021 |
| Absolute humidity and the seasonal onset of influenza in the continental United States J Shaman, VE Pitzer, C Viboud, BT Grenfell, M Lipsitch PLoS biology 8 (2), e1000316, 2010 | 840 | 2010 |
| Antibiotics in agriculture and the risk to human health: how worried should we be? Q Chang, W Wang, G Regev‐Yochay, M Lipsitch, WP Hanage Evolutionary applications 8 (3), 240-247, 2015 | 753 | 2015 |
| Antimicrobial use and antimicrobial resistance: a population perspective M Lipsitch, MH Samore Emerging infectious diseases 8 (4), 347, 2002 | 665 | 2002 |
| Evaluating treatment protocols to prevent antibiotic resistance S Bonhoeffer, M Lipsitch, BR Levin Proceedings of the National Academy of Sciences 94 (22), 12106-12111, 1997 | 589 | 1997 |
| Interleukin-17A mediates acquired immunity to pneumococcal colonization YJ Lu, J Gross, D Bogaert, A Finn, L Bagrade, Q Zhang, JK Kolls, ... PLoS pathogens 4 (9), e1000159, 2008 | 575 | 2008 |
Yonatan GradProfessor of Immunology and Infectious Diseases, Harvard TH Chan School of Public Health在 hsph.harvard.edu 的電子郵件地址已通過驗證
Edward GoldsteinMassachusetts Eye and Ear, Harvard Medical School在 meei.harvard.edu 的電子郵件地址已通過驗證
William HanageHarvard T H Chan School of Public Health在 hsph.harvard.edu 的電子郵件地址已通過驗證Miguel HernánDirector, CAUSALab / Professor of Biostatistics and Epidemiology, Harvard T.H. Chan School在 hsph.harvard.edu 的電子郵件地址已通過驗證
Ted CohenDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health在 yale.edu 的電子郵件地址已通過驗證
Krzysztof TrzcinskiUniversity Medical Centre Utrecht在 umcutrecht.nl 的電子郵件地址已通過驗證
Ran BalicerClalit Research Institute and Ben-Gurion University, Israel在 netvision.net.il 的電子郵件地址已通過驗證
Stephen KisslerUniversity of Colorado Boulder在 colorado.edu 的電子郵件地址已通過驗證
Bruce R. LevinProfessor, Department of Biology, Emory University在 emory.edu 的電子郵件地址已通過驗證
Ben CowlingChair Professor of Epidemiology, School of Public Health, The University of Hong Kong在 hku.hk 的電子郵件地址已通過驗證
Rene NiehusHarvard T.H. Chan School of Public Health在 hsph.harvard.edu 的電子郵件地址已通過驗證
Daniel M WeinbergerYale University在 yale.edu 的電子郵件地址已通過驗證
Sarah CobeyProfessor, University of Chicago在 uchicago.edu 的電子郵件地址已通過驗證
Christophe FraserPandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford在 ndm.ox.ac.uk 的電子郵件地址已通過驗證
